Acute Infectious Keratoconjunctivitis is a condition characterized by the acute inflammation of the cornea (the transparent front part of the eye) and the conjunctiva (the thin, clear tissue that covers the white part of the eye and lines the inside of the eyelids). It is typically caused by a viral or bacterial infection and is highly contagious. Symptoms may include redness, irritation, watery discharge, discomfort, and blurred vision.
At D&H National Research Centers, our mission is clear: to bring hope and relief to individuals suffering from Acute Infectious Keratoconjunctivitis (AIK). Through cutting-edge research and innovative treatments, we aim to better understand this condition and develop more effective strategies for prevention and management.
​
​
​
-
Access to potential treatments: By participating in our clinical trial, you will have the opportunity to improve your AIK symptoms and overall quality of life.
​
-
Expert medical care: The D&H National Research Centers team of healthcare professionals and researchers will closely monitor your progress throughout the trial, ensuring that you receive the highest standard of care and support.
​
-
Participation required: Participation may last for about 2 weeks and includes 5 visits, each lasting about an hour. You will receive study related medication and study-related exams at no cost to you.
​
-
Compensation: As a token of appreciation for your participation, you may be eligible for compensation for your time and travel expenses.
D&H National Research Centers is currently conducting a study on Acute Infectious Keratoconjunctivitis. As a prominent leader in clinical research in Florida, we are committed to advancing medical knowledge and patient care.
Inclusion Criteria:
If you want to participate in this study, you must meet all the following criteria:
​
-
Male or female patient 18 years of age or over.
-
A clinical diagnosis of AIK with a minimum of a 2+ (moderate) conjunctival hyperemia (bulbar redness) and a minimum of 1+ (mild) discharge in at least 1 eye
-
Willing and able to follow all instructions and attend all study visits
Exclusion Criteria:
You are not eligible for participation in this study if:
-
Untreated keratoconjunctivitis of any type that has lasted 96 consecutive hours or more prior to Baseline visit.
-
Infectious blepharitis as the primary cause of conjunctival hyperemia (bulbar redness) and discharge in the opinion of the Investigator (Note: If the blepharitis is secondary to the conjunctivitis, the patient can be included).
-
Suspected allergic conjunctivitis as a primary cause of conjunctival hyperemia (bulbar redness) and/or discharge in the opinion of the Investigator.
-
Suspected corneal ulcer.
D&H National Research Centers is a leading medical trial center located in Florida.
​
If you are interested in joining our Acute Infectious Keratoconjunctivitis (AIK) medical trial or have questions about the study, please don't hesitate to reach out to us.
We are here to provide you with all the information and support you need, please fill the form or contact us by phone: (786) 375-6210